# Samsara Inc.: financial statements, quarterly IOT · NYSE · CIK 1642896 · [Technology](/sectors/technology.md) · fiscal year ends Jan 30 Pages: [Overview](/companies/iot.md) · [Financials](/companies/iot/financials.md) · [Filings](/companies/iot/filings.md) · [Insiders](/companies/iot/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iot/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [238](/filings/0001642896-24-000076.md) | [276 d](/filings/0001628280-26-018167.md) | [281](/filings/0001642896-25-000058.md) | [300](/filings/0001642896-25-000074.md) | [322](/filings/0001628280-25-056069.md) | [346 d](/filings/0001628280-26-018167.md) | [367](/filings/0001628280-26-041893.md) | [391](/filings/0001628280-26-060909.md) | [416](/filings/0001628280-25-056069.md) | [444 d](/filings/0001628280-26-018167.md) | [479](/filings/0001628280-26-041893.md) | [508](/filings/0001628280-26-060909.md) | | Cost of revenue | $m | [61.6](/filings/0001642896-24-000076.md) | [69.0 d](/filings/0001628280-26-018167.md) | [68.6](/filings/0001642896-25-000058.md) | [73.4](/filings/0001642896-25-000074.md) | [76.0](/filings/0001628280-25-056069.md) | [80.3 d](/filings/0001628280-26-018167.md) | [83.2](/filings/0001628280-26-041893.md) | [90.5](/filings/0001628280-26-060909.md) | [97.0](/filings/0001628280-25-056069.md) | [106 d](/filings/0001628280-26-018167.md) | [118](/filings/0001628280-26-041893.md) | [116](/filings/0001628280-26-060909.md) | | Gross profit | $m | [176](/filings/0001642896-24-000076.md) | [207 d](/filings/0001628280-26-018167.md) | [212](/filings/0001642896-25-000058.md) | [227](/filings/0001642896-25-000074.md) | [246](/filings/0001628280-25-056069.md) | [266 d](/filings/0001628280-26-018167.md) | [284](/filings/0001628280-26-041893.md) | [301](/filings/0001628280-26-060909.md) | [319](/filings/0001628280-25-056069.md) | [338 d](/filings/0001628280-26-018167.md) | [361](/filings/0001628280-26-041893.md) | [393](/filings/0001628280-26-060909.md) | | Research and development | $m | [60.8](/filings/0001642896-24-000076.md) | [73.4 d](/filings/0001628280-26-018167.md) | [73.0](/filings/0001642896-25-000058.md) | [76.5](/filings/0001642896-25-000074.md) | [77.0](/filings/0001628280-25-056069.md) | [73.3 d](/filings/0001628280-26-018167.md) | [83.2](/filings/0001628280-26-041893.md) | [85.6](/filings/0001628280-26-060909.md) | [86.2](/filings/0001628280-25-056069.md) | [89.5 d](/filings/0001628280-26-018167.md) | [97.6](/filings/0001628280-26-041893.md) | [103](/filings/0001628280-26-060909.md) | | Operating income | $m | [(54.8)](/filings/0001642896-24-000076.md) | [(123) d](/filings/0001628280-26-018167.md) | [(66.0)](/filings/0001642896-25-000058.md) | [(58.2)](/filings/0001642896-25-000074.md) | [(47.4)](/filings/0001628280-25-056069.md) | [(18.4) d](/filings/0001628280-26-018167.md) | [(33.3)](/filings/0001628280-26-041893.md) | [(26.6)](/filings/0001628280-26-060909.md) | [(1.7)](/filings/0001628280-25-056069.md) | [9.0 d](/filings/0001628280-26-018167.md) | [7.2](/filings/0001628280-26-041893.md) | [4.9](/filings/0001628280-26-060909.md) | | Income tax | $m | [0.1](/filings/0001642896-24-000076.md) | [1.8 d](/filings/0001628280-26-018167.md) | [0.4](/filings/0001642896-25-000058.md) | [1.0](/filings/0001642896-25-000074.md) | [0.5](/filings/0001628280-25-056069.md) | [2.6 d](/filings/0001628280-26-018167.md) | [1.6](/filings/0001628280-26-041893.md) | [1.6](/filings/0001628280-26-060909.md) | [1.3](/filings/0001628280-25-056069.md) | [5.5 d](/filings/0001628280-26-018167.md) | [4.4](/filings/0001628280-26-041893.md) | [1.3](/filings/0001628280-26-060909.md) | | Net income | $m | [(45.5)](/filings/0001642896-24-000076.md) | [(113) d](/filings/0001628280-26-018167.md) | [(56.3)](/filings/0001642896-25-000058.md) | [(49.6)](/filings/0001642896-25-000074.md) | [(37.8)](/filings/0001628280-25-056069.md) | [(11.2) d](/filings/0001628280-26-018167.md) | [(22.1)](/filings/0001628280-26-041893.md) | [(16.8)](/filings/0001628280-26-060909.md) | [7.8](/filings/0001628280-25-056069.md) | [22.0 d](/filings/0001628280-26-018167.md) | [44.5](/filings/0001628280-26-041893.md) | [16.2](/filings/0001628280-26-060909.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001642896-24-000076.md) | not reported | [(0.10)](/filings/0001642896-25-000058.md) | [(0.09)](/filings/0001642896-25-000074.md) | [(0.07)](/filings/0001628280-25-056069.md) | not reported | [(0.04)](/filings/0001628280-26-041893.md) | [(0.03)](/filings/0001628280-26-060909.md) | [0.01](/filings/0001628280-25-056069.md) | not reported | [0.08](/filings/0001628280-26-041893.md) | [0.03](/filings/0001628280-26-060909.md) | | Basic EPS | $ per share | [(0.08)](/filings/0001642896-24-000076.md) | not reported | [(0.10)](/filings/0001642896-25-000058.md) | [(0.09)](/filings/0001642896-25-000074.md) | [(0.07)](/filings/0001628280-25-056069.md) | not reported | [(0.04)](/filings/0001628280-26-041893.md) | [(0.03)](/filings/0001628280-26-060909.md) | [0.01](/filings/0001628280-25-056069.md) | not reported | [0.08](/filings/0001628280-26-041893.md) | [0.03](/filings/0001628280-26-060909.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-10-28) | FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [208](/filings/0001642896-23-000087.md) | [136](/filings/0001642896-25-000022.md) | [162](/filings/0001642896-24-000047.md) | [159](/filings/0001642896-24-000064.md) | [160](/filings/0001642896-24-000076.md) | [228](/filings/0001628280-26-018167.md) | [259](/filings/0001628280-26-041893.md) | [258](/filings/0001628280-26-060909.md) | [275](/filings/0001628280-25-056069.md) | [319](/filings/0001628280-26-060909.md) | [219](/filings/0001628280-26-041893.md) | [291](/filings/0001628280-26-060909.md) | | Current assets | $m | [941](/filings/0001642896-23-000087.md) | [887](/filings/0001642896-25-000022.md) | [924](/filings/0001642896-24-000047.md) | [1,040](/filings/0001642896-24-000064.md) | [1,039](/filings/0001642896-24-000076.md) | [1,212](/filings/0001628280-26-018167.md) | [1,133](/filings/0001642896-25-000058.md) | [1,186](/filings/0001642896-25-000074.md) | [1,258](/filings/0001628280-25-056069.md) | [1,507](/filings/0001628280-26-060909.md) | [1,478](/filings/0001628280-26-041893.md) | [1,573](/filings/0001628280-26-060909.md) | | Total assets | $m | [1,686](/filings/0001642896-23-000087.md) | [1,735](/filings/0001642896-25-000022.md) | [1,749](/filings/0001642896-24-000047.md) | [1,826](/filings/0001642896-24-000064.md) | [1,864](/filings/0001642896-24-000076.md) | [2,024](/filings/0001628280-26-018167.md) | [2,074](/filings/0001642896-25-000058.md) | [2,207](/filings/0001642896-25-000074.md) | [2,314](/filings/0001628280-25-056069.md) | [2,541](/filings/0001628280-26-060909.md) | [2,614](/filings/0001628280-26-041893.md) | [2,769](/filings/0001628280-26-060909.md) | | Current liabilities | $m | [506](/filings/0001642896-23-000087.md) | [592](/filings/0001642896-25-000022.md) | [601](/filings/0001642896-24-000047.md) | [647](/filings/0001642896-24-000064.md) | [654](/filings/0001642896-24-000076.md) | [761](/filings/0001628280-26-018167.md) | [741](/filings/0001642896-25-000058.md) | [792](/filings/0001642896-25-000074.md) | [806](/filings/0001628280-25-056069.md) | [917](/filings/0001628280-26-060909.md) | [912](/filings/0001628280-26-041893.md) | [968](/filings/0001628280-26-060909.md) | | Total liabilities | $m | [735](/filings/0001642896-23-000087.md) | [820](/filings/0001642896-25-000022.md) | [826](/filings/0001642896-24-000047.md) | [861](/filings/0001642896-24-000064.md) | [865](/filings/0001642896-24-000076.md) | [955](/filings/0001628280-26-018167.md) | [946](/filings/0001642896-25-000058.md) | [992](/filings/0001642896-25-000074.md) | [1,010](/filings/0001628280-25-056069.md) | [1,120](/filings/0001628280-26-060909.md) | [1,106](/filings/0001628280-26-041893.md) | [1,167](/filings/0001628280-26-060909.md) | | Shareholders' equity | $m | [951](/filings/0001642896-24-000076.md) | [915](/filings/0001628280-26-018167.md) | [924](/filings/0001642896-25-000074.md) | [965](/filings/0001628280-25-056069.md) | [999](/filings/0001628280-25-056069.md) | [1,069](/filings/0001628280-26-060909.md) | [1,128](/filings/0001628280-26-060909.md) | [1,215](/filings/0001628280-26-060909.md) | [1,303](/filings/0001628280-25-056069.md) | [1,420](/filings/0001628280-26-060909.md) | [1,508](/filings/0001628280-26-060909.md) | [1,602](/filings/0001628280-26-060909.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [11.9 d](/filings/0001642896-24-000076.md) | [(41.9) d](/filings/0001628280-26-018167.md) | [23.7](/filings/0001642896-25-000058.md) | [18.1 d](/filings/0001642896-25-000074.md) | [36.0 d](/filings/0001628280-25-056069.md) | [53.9 d](/filings/0001628280-26-018167.md) | [52.6](/filings/0001628280-26-041893.md) | [50.2 d](/filings/0001628280-26-060909.md) | [63.7 d](/filings/0001628280-25-056069.md) | [69.7 d](/filings/0001628280-26-018167.md) | [81.4](/filings/0001628280-26-041893.md) | [73.5 d](/filings/0001628280-26-060909.md) | | Capital expenditure | $m | [3.4 d](/filings/0001642896-24-000076.md) | [2.1 d](/filings/0001628280-26-018167.md) | [5.1](/filings/0001642896-25-000058.md) | [5.0 d](/filings/0001642896-25-000074.md) | [4.8 d](/filings/0001628280-25-056069.md) | [5.3 d](/filings/0001628280-26-018167.md) | [6.9](/filings/0001628280-26-041893.md) | [6.0 d](/filings/0001628280-26-060909.md) | [7.9 d](/filings/0001628280-25-056069.md) | [8.0 d](/filings/0001628280-26-018167.md) | [8.2](/filings/0001628280-26-041893.md) | [8.8 d](/filings/0001628280-26-060909.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: not reported ## Shares | Line item | Unit | Q3 FY2023 (2022-10-29) | Q1 FY2024 (2023-04-29) | Q2 FY2024 (2023-07-29) | Q3 FY2024 (2023-10-28) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [517](/filings/0001642896-23-000087.md) | [526](/filings/0001642896-24-000047.md) | [532](/filings/0001642896-24-000064.md) | [537](/filings/0001642896-24-000076.md) | [549](/filings/0001642896-25-000058.md) | [554](/filings/0001642896-25-000074.md) | [559](/filings/0001628280-25-056069.md) | [568](/filings/0001628280-26-041893.md) | [572](/filings/0001628280-26-060909.md) | [586](/filings/0001628280-25-056069.md) | [588](/filings/0001628280-26-041893.md) | [590](/filings/0001628280-26-060909.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.